Dr. Dalip Sethi, Ph.D.

Chief Operating Officer

Dr. Dalip Sethi currently serves as Chief Operating Officer for TotipotentRX (Subsidiary of Cesca therapeutics, Inc. (USA). While at Cesca Dr. Sethi also holds the position of Senior Director-Research & Development. Dr. Sethi oversee a robust research program focused on development of automated technologies for cell-based therapeutics and supports clinical development programme that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopaedic markets. Dr. Sethi holds a Ph.D. in Biotechnology from Institute of Genomics & Integrative Biology, New Delhi, and a Masters in Organic Chemistry from Hansraj College, Delhi University, India, and conducted postdoctoral studies at Thomas Jefferson University, School of Medicine (USA). He has authored over twenty publications and has been recognized by numerous professional societies for his contributions to biomedical research.